Big Pharma's Data Dump: Pfizer, AbbVie, Biogen Idec
Three big-cap drug companies dropped news today, likely to give investors time to digest it before next week’s big J.P. Morgan investor meeting in San Francisco. Quick thoughts on each.
1. Biogen Idec BIIB -0.85% announced mixed results of its most important experimental drug, anti-LINGO, in acute optic neuritis, or nerve damage in the eye. The hope is that this drug could regrow nerves in multiple sclerosis patients, becoming the first treatment to reverse that disease.
Hey, check out all the research scientist jobs. Post your resume today!
1. Biogen Idec BIIB -0.85% announced mixed results of its most important experimental drug, anti-LINGO, in acute optic neuritis, or nerve damage in the eye. The hope is that this drug could regrow nerves in multiple sclerosis patients, becoming the first treatment to reverse that disease.
Hey, check out all the research scientist jobs. Post your resume today!